NCT07186933

Brief Summary

The goal of this clinical trial is to compare two different types of perioperative mechanical ventilation (MV), specifically Protective Mechanical Ventilation (PMV) and MV with the lowest possible Driving Pressure (ΔP), in relation to the appearance of postoperative pulmonary complications (PPCs) in adult patients who are operated and have higher risk of PPCs. The main questions it aims to answer are:

  • Is MV with lower ΔP better than conventional PMV in preventing PPCs in patients with higher risk for PPCs?
  • Does MV with lower ΔP decrease hospital stay, Intensive Care Unit (ICU) need and mortality?
  • Does MV with lower ΔP suit better than PMV to lung characteristics and needs intraoperatively? Researchers will compare MV with the lowest possible Driving Pressure (ΔP) to Protective Mechanical Ventilation (PMV) to see if any of this is more protective than the other concerning PPCs. All participants will receive perioperative MV. Half of them will receive conventional Protective Mechanical Ventilation (PMV). This will include well known generally protective settings for mechanical ventilation of patients, concerning volumes, pressures, respiratory rate, inspiratory gases and ventilation maneuvers. The rest of participants will be ventilated with the lowest possible Driving Pressure (ΔP). This will be similar to PMV in the chosen volumes, respiratory rate, inspiratory gases and ventilation maneuvers. However, the pressure inside lung at the end of expiration, eg Positive End Expiratory Pressure (PEEP), will be not be preset for every patient. Initially, the investigators will perform a maneuver that will quantify each individual's lung characteristics and mechanics. According to this, the investigators will find the exact PEEP that seems to suit each patients lungs most, and use this perioperatively, trying to provide lungs the best conditions every time. After the completion of the operation, all the patients will be screened for PPCs, via arterial blood testing and chest X ray, and the results will be statistically analyzed trying to find if any of the forementioned strategies of mechanical ventilation surpasses the other concerning PPCs appearance. PPCs include atelectasis, respiratory failure, bronchospasm, pleural effusion, pneumonia, aspiration and pneumothorax. Furthermore hospital stay, ICU need and mortality will be noted. Finally, measurements of perioperative lung pressures, volumes and derived variables will be noted and compared statistically as well.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
18mo left

Started Nov 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress30%
Nov 2025Nov 2027

First Submitted

Initial submission to the registry

August 20, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 22, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

November 3, 2025

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2027

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2027

Last Updated

February 11, 2026

Status Verified

February 1, 2026

Enrollment Period

1.8 years

First QC Date

August 20, 2025

Last Update Submit

February 8, 2026

Conditions

Keywords

Driving PressureMechanical PowerAtelectasisPulmonary ComplicationsPostoperative Pulmonary ComplicationsPostoperative Respiratory FailureElastic Power

Outcome Measures

Primary Outcomes (1)

  • Postoperative Pulmonary Complications

    Number of the following Postoperative Pulmonary Complications 1. Postoperative Atelectasis (based on Chest X-Ray in Post-Anesthesia Care Unit - PACU) 2. Postoperative Respiratory Failure based on Arterial Blood Gases in PACU (type I and/or II) 3. Postoperative Bronchospasm 4. Postoperative Pleural Effusion 5. Postoperative Pneumonia 6. Postoperative Aspiration Pneumonitis 7. Postoperative Postoperative Pneumothorax

    Atelectasis -> Within 1 hour in PACURespiratory failure -> Immediately postoperatively & after 30 minutes in PACU.Bronchospasm, Pleural Effusion, Pneumonia, Aspiration Pneumonitis, Pneumothorax -> from immediately postoperative until end of study

Secondary Outcomes (8)

  • Hospital Stay

    From day of operation until the end of patient stay inside hospital, because of return to home or due to death.

  • ICU need.

    From day of operation until the end of patient stay inside hospital, because of return to home or due to death.

  • ICU stay

    From day of operation until the end of patient stay inside hospital, because of return to home or due to death.

  • 28 Day mortality

    From day of operation until up to 28 days.

  • Mechanical Power (MP)

    From the moment of beginning of operation until the moment of the end of operation and mechanical ventilation

  • +3 more secondary outcomes

Study Arms (2)

Lung Protective Ventilation

OTHER

CONVENTIONAL LUNG PROTECTIVE VENTILATION This group is mechanically ventilated with Invasive Mechanical Ventilation with PEEP 8 cm H20 Tidal Volume (VT) 8 ml/kg Ideal Body Weight (IBW) Respiratory Rate (RR) --\> Arterial Partial CO2 Pressure (PaCO2) = 35-45 mmHg Inspired Oxygen Fracture (FiO2) 0.4 - 0.5 --\> Peripheral Oxygen Saturation (SpO2) \> 93% Recruitment Maneuver (as described) every hour

Procedure: Lung Protective Ventilation

Minimum Driving Pressure

ACTIVE COMPARATOR

This group is mechanically ventilated with Invasive Mechanical Ventilation with PEEP; Initially 8 cm H2. Titrated at level with Minimum Driving Pressure after first recruitment - titration maneuver followed by new recruitment maneuver VT 8 ml/kg IBW RR --\> PaCO2 = 35-45 mmHg FiO2 0.4 - 0.5 --\> SpO2 \> 93% Recruitment Maneuver (as described) every hour

Procedure: PEEP titration for Minimum Driving Pressure

Interventions

This group is mechanically ventilated with Invasive Mechanical Ventilation with Volume Control Ventilation mode with PEEP Initially 8 cm H2O. Afterwards, the lungs are recruited with the aforementioned maneuver. During subsequent derecruitment, PEEP is decreased by 2 cm H20 and compliance is noted in each stage. The goal is to find PEEP with maximum compliance (Cmax). A new recruitment maneuver follows and during derecruitment PEEP is set at the optimum value that was previously defined. VT 8 ml/kg IBW RR --\> PaCO2 = 35-45 mmHg FiO2 0.4 - 0.5 --\> SpO2 \> 93% Recruitment Maneuver (as described) every hour

Also known as: Maximum compliance mechanical ventilation, Cmax Mechanical Ventilation
Minimum Driving Pressure

This group is mechanically ventilated with Invasive Mechanical Ventilation with Volume Control Ventilation mode with PEEP 8 cm H2O. VT 8 ml/kg IBW RR --\> PaCO2 = 35-45 mmHg FiO2 0.4 - 0.5 --\> SpO2 \> 93% Recruitment Maneuvers (as described) every hour

Lung Protective Ventilation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \>17 years old
  • Surgery with general anesthesia \& invasive mechanical ventilation
  • Preoperative ARISCAT score estimation \>25

You may not qualify if:

  • \<18 years old
  • Preoperative ARISCAT score estimation \<26
  • Women during pregnancy or just given birth
  • Other type of anesthesia (Not general)
  • Contraindication of administration of neuromuscular blockade agents.
  • Contraindication of cease of spontaneous ventilation.
  • Mechanical ventilation without endotracheal intubation.
  • Severe heart failure / Severe cardiac arrhythmia.
  • Severe emphysematous lung disease.
  • Patient denial of participation in the trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Patras

Pátrai, 26504, Greece

RECRUITING

MeSH Terms

Conditions

Pulmonary Atelectasis

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract Diseases

Study Officials

  • Diamanto Aretha, A. Professor

    University of Patras

    STUDY DIRECTOR
  • Antonios Kostouros, Resident

    University of Patras

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Antonios D Kostouros, Resident

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prinsipal Investigator, Antonios Kostouros

Study Record Dates

First Submitted

August 20, 2025

First Posted

September 22, 2025

Study Start

November 3, 2025

Primary Completion (Estimated)

August 31, 2027

Study Completion (Estimated)

November 30, 2027

Last Updated

February 11, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

Excel file per patient containing all the collected data Preoperatively; Patient demographics, ARISCAT score Perioperatively; Mechanical ventilation settings and measurements. Type and duration of operation. Anesthetic methods. Aerial blood gases results. Data from haemodynamic monitoring. Quantity of crystalloids , vasoperessors and inotropes. Postoperatively; Arterial blood gases results in PACU, Potential presence of other postoperative pulmonary complications. Statistic analysis of the collected data

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
Beginning at the end of data collection, possibly August 2027. Ending 3 years after publication of results.
Access Criteria
Reviewers. Researchers of relevant subjects. Anesthesiologists with interest in optimum mechanical ventilation. A request via email will be initially needed. A data sharing agreement will be needed to be signed.

Locations